GREGORY GLADISH to Antineoplastic Agents
This is a "connection" page, showing publications GREGORY GLADISH has written about Antineoplastic Agents.
Connection Strength
0.081
-
The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. Methodist Debakey Cardiovasc J. 2019 Oct-Dec; 15(4):258-266.
Score: 0.035
-
Cardiac complications of oncologic therapy. Radiographics. 2013 Oct; 33(6):1801-15.
Score: 0.023
-
Development of pulmonary arteriovenous communications within pulmonary metastases after chemotherapy. J Thorac Oncol. 2007 Mar; 2(3):243-6.
Score: 0.015
-
Incidence and risk factors of venous thromboembolic events in lymphoma. Am J Med. 2010 Oct; 123(10):935-41.
Score: 0.005
-
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer. Cancer. 2005 Dec 01; 104(11):2449-56.
Score: 0.003